Credit Suisse’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,900
Closed -$3.56M 3965
2021
Q4
$3.56M Sell
9,900
-9,900
-50% -$3.41M ﹤0.01% 2307
2021
Q3
$6.56M Hold
19,800
﹤0.01% 1838
2021
Q2
$6.07M Buy
19,800
+4,200
+27% +$1.18M ﹤0.01% 1929
2021
Q1
$3.84M Sell
15,600
-39,600
-72% -$9.96M ﹤0.01% 2299
2020
Q4
$15.1M Buy
55,200
+29,400
+114% +$7.3M 0.01% 1340
2020
Q3
$6.1M Buy
25,800
+7,500
+41% +$1.68M ﹤0.01% 1656
2020
Q2
$3.48M Buy
18,300
+7,800
+74% +$1.4M ﹤0.01% 1952
2020
Q1
$1.73M Sell
10,500
-61,800
-85% -$11.3M ﹤0.01% 2231
2019
Q4
$14.2M Buy
72,300
+14,100
+24% +$2.64M 0.01% 1216
2019
Q3
$10.5M Buy
58,200
+7,200
+14% +$1.25M 0.01% 1282
2019
Q2
$8.92M Buy
51,000
+45,600
+844% +$7.81M 0.01% 1385
2019
Q1
$1.03M Buy
+5,400
New +$960K ﹤0.01% 2869
2015
Q2
Sell
-90,000
Closed -$5.05M 4578
2015
Q1
$5.05M Buy
+90,000
New +$5.09M 0.01% 1660

Other funds holding ISRG

Credit Suisse's ISRG Position: Q1 2024 in Review

Credit Suisse reduced its Intuitive Surgical (ISRG) stake by 16% in Q1 2024, selling an estimated $52.4M and leaving 747,649 shares worth $298M. The position accounts for 0.29% of the portfolio, ranked #61.

Credit Suisse first reported a position in ISRG in Q2 2013 and has held it in 44 quarters since. The position peaked at $482M in Q3 2021. 1,742 funds tracked by Wall St. Rank hold ISRG as of Q1 2024.

  • Credit Suisse held 747,649 shares of Intuitive Surgical worth $298M as of Q1 2024.
  • Credit Suisse sold 138,689 Intuitive Surgical shares in Q1 2024, an estimated $52.4M.
  • Intuitive Surgical made up 0.29% of Credit Suisse's portfolio in Q1 2024, its #61 holding.
  • Credit Suisse first reported a position in Intuitive Surgical in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Intuitive Surgical position peaked at $482M in Q3 2021.
  • 1,742 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.